The 2nd Intersessional Meeting of the 61st session of the Commission on Narcotic Drugs took place in Vienna on the 25th of June 2018. The meeting started with Chair Alicia Buenrostro Massieu of Mexico presenting the agenda for adoption, then proceeded to the first agenda point: Follow-up to the regular 61st session of CND, resolution …
Belgium
Committee of the Whole – Friday afternoon (L2 – Protecting children from illicit drug threat)
Chair: We are going to take on L2, then go back to L11 Russia: We are ready to go and wish to be flexible. Chair: Comments on the title? Russia: We’re running out of time; we are happy to reframe the title: ‘Protecting children from the illicit drug challenge’ Chair: Title approved. Russia: These are …
Committee of the Whole (Friday Morning and Afternoon) – Resolution L11. Removing stigma as a barrier to the availability and delivery of health, case and social services for people who use drugs
Canada: it’s not the first time I’ve seen this text. We’ve done a thorough analysis and we think this is worthy of showing the COW? ‘Alt PP13bis Acknowledging that removing stigmatising attitudes includes long term comprehensive multidisciplinary and balanced efforts by member states, in full conformity with the Universal Declaration of Human Rights, the Universal …
Plenary Session: Item 7. Follow-up to the special session of the General Assembly on the world drug problem held in 2016, including the seven thematic areas of the outcome document of the special session.
Chair: Member states committed to report timely on their progress in implementing the recommendations set out in the Outcome Document. The Commission held two rounds of discussion in 2016 and decided to continue holding such discussions; a third thematic discussion was held in 2017. Ambassador Moitinho de Almeida of Portugal: As CND facilitator for the …
Committee of the Whole (Thursday Afternoon) – Resolution L11. Removing stigma as a barrier to the availability and delivery of health, case and social services for people who use drugs
L11 Chair: We may not move in chronological order. I want to mention I intend to continue our session in the evening because we have very little time left. I invite us to focus on L11. China: Regarding the night session we have some concerns because we have many experts who wish to speak in …
Special Event: Taking Action to Increase Access to Controlled Drugs for Medical Purposes While Preventing Diversion and Misuse
Dr Lisa Studdert, Australia’s Head of Delegation Australia is deeply concern on the global disparity on global access to essential medicines. We need to work together. Adequate provision must be made to ensure access. It’s very important that the conventions do no restrict access. We need to reduce the risks of diversion for illicit use. …